当前位置：
X-MOL 学术
›
J. Am. Soc. Nephrol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Efficacy and Safety of Ravulizumab in IgA Nephropathy: A Phase 2 Randomized Double-Blind Placebo-Controlled Trial.
Journal of the American Society of Nephrology ( IF 10.3 ) Pub Date : 2024-10-25 , DOI: 10.1681/asn.0000000534 Richard Lafayette,James Tumlin,Roberta Fenoglio,Jessica Kaufeld,Miguel Ángel Pérez Valdivia,Mai-Szu Wu,Shih-Han Susan Huang,Eric Alamartine,Sung Gyun Kim,Min Yee,Andreas Kateifides,Kara Rice,Katherine Garlo,Jonathan Barratt,
中文翻译：
Ravulizumab 在 IgA 肾病中的疗效和安全性：一项 2 期随机双盲安慰剂对照试验。
更新日期：2024-10-25
Journal of the American Society of Nephrology ( IF 10.3 ) Pub Date : 2024-10-25 , DOI: 10.1681/asn.0000000534 Richard Lafayette,James Tumlin,Roberta Fenoglio,Jessica Kaufeld,Miguel Ángel Pérez Valdivia,Mai-Szu Wu,Shih-Han Susan Huang,Eric Alamartine,Sung Gyun Kim,Min Yee,Andreas Kateifides,Kara Rice,Katherine Garlo,Jonathan Barratt,
中文翻译：
Ravulizumab 在 IgA 肾病中的疗效和安全性：一项 2 期随机双盲安慰剂对照试验。
京公网安备 11010802027423号